|
BIOSTEM TECHNOLOGIES INC.
US SYMBOL: BSEM
Last Price: 3.80 | Website | Latest News
If you've been following our alerts, you know 2025 has been a record year here... but hold on we are not done yet!
Operating in the MedTech space with cutting-edge regenerative medicine, ROARING REVENUE GROWTH, and a unique Triangle Breakout Chart now tightening into place, this setup is demanding attention.
WE ARE ISSUING AN IMMEDIATE ALERT ON BSEM!
The future is regenerative medicine and BioStem Technologies (OTC: BSEM) is leading the way with innovation, exploding revenues, and breakthrough achievements!
This growing Medtech company is harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies in advanced wound care. BSEM is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method.
BSEM manufactures perinatal tissue allografts at the highest levels of quality, leveraging their BioREtain method to focus on maintaining natural growth factors and preserving tissue structure.
BSEM's allografts, including VENDAJE®, VENDAJE AC®, VENDAJE OPTIC® and AmnioWrap2TM are trusted by top clinicians across a range of specialties.
So it should come as no wonder why BSEM has seen Revenues EXPLODE and why there's so much talk of a NASDAQ UPLIST....
In just the last year alone, BSEM generated over $301 MILLION DOLLARS in Revenues compared to $16.6 Million the previous year. That's a 1,857% INCREASE!!
Now compared to 2021 - that's a 6,855% REVENUE BOOM in just 4 years!!
Talk about SUCCESS!!
Yet BSEM still trades on the OTC Markets at around a mere $4.00 with 407% UPSIDE at its 52-week high of $19.28.
BSEM, recently appointed KPMG - one of the Big Four accounting firms - as its new independent auditor and is actively pursing uplisting to NASDAQ. This makes perfect sense... a company with MASSIVE Revenues like this should be trading with the big boys!
Even BSEM's CEO has LOADED UP on shares!!
BSEM POISED FOR A MASSIVE TRIANGLE BREAKOUT?
No doubt - BSEM has already had a history of rallies, but what is forming here, investors should not ignore.
BSEM has developed into a Triangle Breakout Pattern with strong signs of a Bullish run. Take a look...
 Could
Keep in mind, a return to its 52-week high of 19.28 would generate 407% GAINS!
THE BOTTOM LINE
We don't see setups like this every day. A MedTech company with Record-Breaking Revenue Growth to the tune of $301 MILLION yet still trades on the OTC?
With KPMG, one of the "BIG FOUR" accounting giants helping push toward a NASDAQ uplisting... it may not be long before this $4 play goes mainstream!
Keep in mind, BSEM's CEO is also BUYING more shares of BSEM at these low prices!!
Plays with a potential NASDAQ uplists don't come around often. You're going to want to have BSEM on your radar BEFORE it goes mainstream!
Make sure you put it on your screen RIGHT NOW and
Follow on Twitter for Updates + Play-by-Play!
|
